Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1975 Feb;31(2):170–175. doi: 10.1038/bjc.1975.22

Changes in host immunity following excision of a murine melanoma.

A E Bray, D Keast
PMCID: PMC2009396  PMID: 1164467

Abstract

Changes in cell mediated and humoral immunity following the excision of a transplantable melanoma growing in the footpad of its syngeneic host, as measured by an in vitro cytotoxicity test, were assessed. Spleen cell cytotoxicity did not change significantly. Cells from the regional lymph nodes stimulated tumour growth before tumour excision. Three days following tumour excision this stimulatory effect was undetectable. Loss of serum factors capable of blocking the cytotoxicity of spleen cells occurred 24 h after tumour excision. Serum cytotoxicity increased after tumour excision to a maximum of the third day. Following tumour excision the rise in serum cytotoxicity and loss of regional lymph node tumour stimulation were concomitant with the loss of blocking activity.

Full text

PDF
170

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander P., Bensted J., Delorme E. J., Hall J. G., Hodgett J. The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour. Proc R Soc Lond B Biol Sci. 1969 Nov 18;174(1035):237–251. doi: 10.1098/rspb.1969.0090. [DOI] [PubMed] [Google Scholar]
  2. Baldwin R. W., Embleton M. J., Robins R. A. Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status. Int J Cancer. 1973 Jan 15;11(1):1–10. doi: 10.1002/ijc.2910110102. [DOI] [PubMed] [Google Scholar]
  3. Basham C., Currie G. A. Development of specific cell-dependent antibody during growth of a syngeneic rat sarcoma. Br J Cancer. 1974 Mar;29(3):189–198. doi: 10.1038/bjc.1974.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Croce C. M., Koprowski H., Eagle H. Effect of environmental pH on the efficiency of cellular hybridization. Proc Natl Acad Sci U S A. 1972 Jul;69(7):1953–1956. doi: 10.1073/pnas.69.7.1953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Currie G. A., Gage J. O. Influence of tumour growth on the evolution of cytotoxic lymphoid cells in rats bearing a spontaneously metastasizing syngeneic fibrosarcoma. Br J Cancer. 1973 Aug;28(2):136–146. doi: 10.1038/bjc.1973.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Currie G. The role of circulating antigen as an inhibitor of tumour immunity in man. Br J Cancer Suppl. 1973 Aug;1:153–161. [PMC free article] [PubMed] [Google Scholar]
  7. Fidler I. J. Immunostimulation-inhibition of tumor cell growth in vitro utilizing tumor target cells labeled with 125I-iodo-deoxyuridine. Immunol Commun. 1973;2(5):483–493. doi: 10.3109/08820137309022820. [DOI] [PubMed] [Google Scholar]
  8. Flannery G. R., Chalmers P. J., Rolland J. M., Nairn R. C. Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy. Br J Cancer. 1973 Aug;28(2):118–122. doi: 10.1038/bjc.1973.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hellström I., Warner G. A., Hellström K. E., Sjögren H. O. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma. Int J Cancer. 1973 Mar 15;11(2):280–292. doi: 10.1002/ijc.2910110206. [DOI] [PubMed] [Google Scholar]
  10. Hellström K. E., Hellström I. Some aspects of the immune defense against cancer. I. In vitro studies on animal tumors. Cancer. 1971 Nov;28(5):1266–1268. doi: 10.1002/1097-0142(1971)28:5<1266::aid-cncr2820280525>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  11. Heppner G. H. In vitro studies on cell-mediated immunity following surgery in mice sensitized to syngeneic mammary tumors. Int J Cancer. 1972 Jan 15;9(1):119–125. doi: 10.1002/ijc.2910090114. [DOI] [PubMed] [Google Scholar]
  12. Hill B. T., Harrap K. R. The uptake and utilization of chlorambucil by lymphocytes from patients with chronic lymphocytic leukaemia. Br J Cancer. 1972 Dec;26(6):439–443. doi: 10.1038/bjc.1972.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. KLEIN G., SJOGREN H. O., KLEIN E., HELLSTROM K. E. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res. 1960 Dec;20:1561–1572. [PubMed] [Google Scholar]
  14. Medina D., Heppner G. Cell-mediated "immunostimulation" induced by mammary tumour virus-free Balb-c mammary tumours. Nature. 1973 Mar 30;242(5396):329–330. doi: 10.1038/242329a0. [DOI] [PubMed] [Google Scholar]
  15. PREHN R. T., MAIN J. M. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst. 1957 Jun;18(6):769–778. [PubMed] [Google Scholar]
  16. Perper R. J., Zee T. W., Mickelson M. M. Purification of lymphocytes and platelets by gradient centrifugation. J Lab Clin Med. 1968 Nov;72(5):842–848. [PubMed] [Google Scholar]
  17. Prehn R. T. The immune reaction as a stimulator of tumor growth. Science. 1972 Apr 14;176(4031):170–171. doi: 10.1126/science.176.4031.170. [DOI] [PubMed] [Google Scholar]
  18. SUGIURA K., STOCK C. C. Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat tumors. Cancer Res. 1955 Jan;15(1):38–51. [PubMed] [Google Scholar]
  19. Sjögren H. O., Hellström I., Bansal S. C., Hellström K. E. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372–1375. doi: 10.1073/pnas.68.6.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Takasugi M., Klein E. A microassay for cell-mediated immunity. Transplantation. 1970 Mar;9(3):219–227. doi: 10.1097/00007890-197003000-00005. [DOI] [PubMed] [Google Scholar]
  21. Thomson D. M., Steele K., Alexander P. The presence of tumour-specific membrane antigen in the serum of rats with chemically induced sarcomata. Br J Cancer. 1973 Jan;27(1):27–34. doi: 10.1038/bjc.1973.4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES